)
)
)
Grace Therapeutics
Grace Therapeutics is a late-stage biopharma with a target PDUFA date of 2Q'26 for GTx-104. GTx-102 ready to initiative pivotal Ph 3. Partnership opportunities including in-licensing CNS, immunology and oncology.
Address
PrincetonNJ
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)